Hospital La Católica: A Beacon of Opportunity Enters Panama Stock Exchange
Costa Rican Medical Giant Invites Broader Investment Access and Eyes Expansion
In a strategic leap aimed at expanding its investment horizon, Hospital Internacional La Católica, a prominent medical institution, has announced its entry into the Panama Stock Exchange.
Revealed on Tuesday, December 17, this move signals the hospital's ambition to broaden the scope of its financial engagements by offering investment opportunities traditionally restricted to institutional and substantial investors.
Partnering with Bicsa Capital Panamá and Inversiones SAMA, a Costa Rican brokerage firm, La Católica aims to facilitate public trading of its shares.
Javier Herrera, the hospital's Commercial Director, confirms that this market participation will offer potential investors the chance to acquire convertible preferred shares alongside common stocks.
While common shares confer voting rights and dividend entitlement, preferred shares, though devoid of voting privileges, prioritize dividend payments.
Herrera emphasizes, "By listing on the stock exchange, the hospital strives to deepen its connection with physicians and clients, empowering them to become stakeholders in the medical center.
This initiative unveils an investment opportunity in a sector often reserved for affluent corporate entities and institutional investors."
The hospital's robust financial standing is underscored by its recent BBB+ stable outlook rating awarded by Moody’s, highlighting its strong fiscal performance and instilling confidence among investors.
This milestone follows La Católica's prior announcement in February last year about a $65 million capital infusion aimed at significant expansions, enhancements, and new constructions over an impressive 48,000 square meters.
The hospital, having reclaimed its property from BCR Sociedad Administradora de Fondos de Inversión for $36.7 million, marks a new chapter in its developmental arc, previously involving a lease from the Fund managed by BCR SAFI.
With its foray into the Panama Stock Exchange, Hospital La Católica not only opens its doors to individual investors but also bolsters its capacity for future growth, extending its reach in the Central American healthcare landscape.
Revealed on Tuesday, December 17, this move signals the hospital's ambition to broaden the scope of its financial engagements by offering investment opportunities traditionally restricted to institutional and substantial investors.
Partnering with Bicsa Capital Panamá and Inversiones SAMA, a Costa Rican brokerage firm, La Católica aims to facilitate public trading of its shares.
Javier Herrera, the hospital's Commercial Director, confirms that this market participation will offer potential investors the chance to acquire convertible preferred shares alongside common stocks.
While common shares confer voting rights and dividend entitlement, preferred shares, though devoid of voting privileges, prioritize dividend payments.
Herrera emphasizes, "By listing on the stock exchange, the hospital strives to deepen its connection with physicians and clients, empowering them to become stakeholders in the medical center.
This initiative unveils an investment opportunity in a sector often reserved for affluent corporate entities and institutional investors."
The hospital's robust financial standing is underscored by its recent BBB+ stable outlook rating awarded by Moody’s, highlighting its strong fiscal performance and instilling confidence among investors.
This milestone follows La Católica's prior announcement in February last year about a $65 million capital infusion aimed at significant expansions, enhancements, and new constructions over an impressive 48,000 square meters.
The hospital, having reclaimed its property from BCR Sociedad Administradora de Fondos de Inversión for $36.7 million, marks a new chapter in its developmental arc, previously involving a lease from the Fund managed by BCR SAFI.
With its foray into the Panama Stock Exchange, Hospital La Católica not only opens its doors to individual investors but also bolsters its capacity for future growth, extending its reach in the Central American healthcare landscape.
